enkephalin, leucine has been researched along with Neurodegenerative Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aigner, C; Herzog, H; Schunk, E; Schwarzer, C; Stefanova, N; Wenning, G | 1 |
Hui, KS | 1 |
1 review(s) available for enkephalin, leucine and Neurodegenerative Diseases
Article | Year |
---|---|
Brain-specific aminopeptidase: from enkephalinase to protector against neurodegeneration.
Topics: Aminopeptidases; Animals; Brain; Enkephalins; Humans; Hydrolysis; Neprilysin; Neurodegenerative Diseases; Neurons; Opioid Peptides | 2007 |
1 other study(ies) available for enkephalin, leucine and Neurodegenerative Diseases
Article | Year |
---|---|
Kappa opioid receptor activation blocks progressive neurodegeneration after kainic acid injection.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; CA1 Region, Hippocampal; Enkephalins; Guanidines; Humans; Interneurons; Kainic Acid; Mice; Mice, Inbred C57BL; Mice, Knockout; Morphinans; Neurodegenerative Diseases; Protein Precursors; Pyramidal Cells; Receptors, Opioid, kappa; Seizures | 2011 |